A detailed history of Gratus Capital LLC transactions in Liquidia Corp stock. As of the latest transaction made, Gratus Capital LLC holds 45,000 shares of LQDA stock, worth $514,800. This represents 0.02% of its overall portfolio holdings.

Number of Shares
45,000
Previous 45,000 -0.0%
Holding current value
$514,800
Previous $663,000 18.55%
% of portfolio
0.02%
Previous 0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$11.35 - $16.73 $510,750 - $752,850
45,000 New
45,000 $663,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $736M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.